Clinical Trials
4 trialsNCT00411528 2020-12-17
Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
Novartis
Phase 2 Completed
NCT00035113 2017-02-09
EPO906 Therapy in Patients With Prostate Cancer
Novartis
Phase 2 Completed
NCT00035243 2012-04-17
EPO906 Therapy in Patients With Advanced Kidney Cancer
Novartis
Phase 2 Completed
NCT00407251 2010-11-05
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
British Columbia Cancer Agency
Phase 2 Completed